Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,078,716 | 1,250,737 | 956,978 | 781,643 | 1,211,762 |
| Depreciation Amortization | 715,348 | 723,860 | 745,443 | 732,602 | 680,615 |
| Income taxes - deferred | 86,574 | -57,840 | -39,354 | -75,669 | 60,483 |
| Accounts receivable | -210,632 | -29,766 | 172,361 | -148,394 | -138,140 |
| Accounts payable and accrued liabilities | 128,303 | 1,699 | 26,890 | 87,481 | -30,320 |
| Other Working Capital | -263,241 | -29,821 | 194,535 | 101 | -140,639 |
| Other Operating Activity | 351,432 | 163,169 | 2,178 | 186,806 | 287,115 |
| Operating Cash Flow | $1,886,500 | $2,022,038 | $2,059,031 | $1,564,570 | $1,930,876 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 46,105 | 18,064 | 100,438 | -58,487 | -5,957 |
| PPE Investments | -541,691 | -529,581 | -537,375 | -603,429 | -641,465 |
| Net Acquisitions | -117,468 | -246,068 | -26,394 | -57,308 | -187,050 |
| Purchase Of Investment | -43,435 | -20,524 | -313,382 | -31,885 | -13,924 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 117,582 | 61,464 |
| Other Investing Activity | 1,540 | 6,680 | 4,913 | 120,762 | 63,663 |
| Investing Cash Flow | $-654,949 | $-771,429 | $-771,800 | $-630,347 | $-784,733 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,612,280 | 6,624,310 | 2,468,341 | 2,393,116 | 1,615,370 |
| Debt Repayment | -4,788,845 | -5,515,213 | -3,020,956 | -2,404,395 | -861,115 |
| Common Stock Issued | 23,290 | 20,453 | 16,900 | 18,577 | -60,001 |
| Common Stock Repurchased | -1,792,999 | -1,385,932 | -272,219 | -802,228 | -1,538,626 |
| Other Financing Activity | -428,506 | -560,555 | -362,561 | -326,198 | -238,594 |
| Financing Cash Flow | $-1,374,780 | $-816,937 | $-1,170,495 | $-1,121,128 | $-1,082,966 |
| Exchange Rate Effect | 21,151 | -18,481 | 8,909 | -29,066 | -10,007 |
| Beginning Cash Position | 879,825 | 464,634 | 338,989 | 554,960 | 501,790 |
| End Cash Position | 757,747 | 879,825 | 464,634 | 338,989 | 554,960 |
| Net Cash Flow | $-122,078 | $415,191 | $125,645 | $-215,971 | $53,170 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,886,500 | 2,022,038 | 2,059,031 | 1,564,570 | 1,930,876 |
| Capital Expenditure | -575,864 | -555,443 | -567,985 | -603,429 | -641,465 |
| Free Cash Flow | 1,310,636 | 1,466,595 | 1,491,046 | 961,141 | 1,289,411 |